Mykaela Percy, LPN in Haleiwa, HI - Licensed Practical Nurse

Mykaela Percy, LPN is a Licensed Practical Nurse based in Haleiwa, Hawaii. Mykaela Percy is licensed to practice in Hawaii (license number 19896) and her current practice location is 66-505 Haleiwa Rd, Haleiwa, Hawaii. She can be reached at her office (for appointments etc.) via phone at (808) 637-8237.

NPI number for Mykaela Percy is 1154937589 and her current mailing address is 120 Komohana Ct Unit 201, Wahiawa, Hawaii. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154937589.

Contact Information

	Mykaela Percy, LPN
	66-505 Haleiwa Rd, Haleiwa, HI 96712-1599
	(808) 637-8237
	Not Available

Provider's Profile

Full Name	Mykaela Percy
Gender	Female
Speciality	Licensed Practical Nurse
Location	66-505 Haleiwa Rd, Haleiwa, Hawaii
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1154937589
Provider Enumeration Date: 09/21/2020
Last Update Date: 09/21/2020

Medical Identifiers

Medical identifiers for Mykaela Percy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154937589	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	19896 (Hawaii)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mykaela Percy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mykaela Percy, LPN 120 Komohana Ct Unit 201, Wahiawa, HI 96786-5446 Ph: (573) 855-6950	Mykaela Percy, LPN 66-505 Haleiwa Rd, Haleiwa, HI 96712-1599 Ph: (808) 637-8237

News Archive

GlobalPost examines effects of China's 'one-child policy'

"The time may finally be near for the Chinese government to back away from one of its most famous - and controversial - laws," the so-called "one-child policy," GlobalPost reports.

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.

Study confirms high biocompatibility of polymeric materials with brain tissue

Professor José Miguel Soria, a member of the Institute of Biomedical Sciences, Universidad CEU Cardenal Herrera, has co-directed with Professor Manuel Monleón of the Universitat Politècnica de València a study on the compatibility of polymeric biomaterials in the brain and its effectiveness to favour neuroregeneration in areas with some kind of damage or brain injury.

New tablet-sized device can profile multiple COVID-19 antibodies and biomarkers simultaneously

Biomedical engineers at Duke University in the USA have developed a device that detects coronavirus disease (COVID-19) antibodies as well as biomarkers that distinguish between antibodies produced in response to SARS-CoV-2 and four other coronaviruses with complete accuracy.

Mykaela Percy, LPN - Licensed Practical Nurse in Haleiwa, HI